Verastem Inc (VSTM) Stock Price, Quote & News

Company Profile

Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK kinase activity and the compensatory reactivation of MEK by upstream RAF, thereby targeting the RAS/MAPK signaling pathway that is commonly activated in various cancers; and Defactinib, an oral small mole...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 292 4200

Website: www.verastem.com

Address:

117 Kendrick Street, Suite 500, Needham, United States

MSUalum Aug. 19 at 4:17 PM

$VSTM looking for a quick and strong move to 10 now.

1 · Reply

toradio Aug. 19 at 2:24 PM

$VSTM Gap closed....now which way will it move??

1 · Reply

JohnBiotech Aug. 19 at 2:12 PM

$VSTM

2 · Reply

NYBomba Aug. 19 at 1:33 PM

$VSTM - now RSI is in the 70s with MACD n OBV high against the ceiling plus revisiting the Golden Cross soon. institutions practically own the float and the only short interest is their hedge… chart looks ready to burst…

1 · Reply

Alt_Fuel Aug. 19 at 1:06 PM

$VSTM $MRNA $MRK VERASTEM - KRAS Targeted Drugs https://www.verastem.com/our-science/kras-g12d-inhibition/ Adam Feuerstein ✡️ @adamfeuerstein I have to say, when Merck called me last night with the mRNA cancer vaccine news (embargoed, of course), I literally yelped in reaction. Consider this: Between this spring's $RVMD Revolution Medicines success with a KRAS-targeted drug and now Merck and Moderna's success with an mRNA neoantigen vaccine, 2026 will go down as one of the most consequential years in cancer treatment, ever. Incredible. 6:58 AM · Aug 19, 2026 · 51.5K Views https://x.com/adamfeuerstein/status/2090030711109451810

0 · Reply

sweddle Aug. 19 at 12:18 PM

$VSTM

0 · Reply

Alt_Fuel Aug. 19 at 11:05 AM

$VSTM $ERAS $RVMD $MRNA $MRK When Oncology Science is successful ... Moderna & Merck : Intismeran Phase 3 Trial Met Primary Goal; Trial Showed Shot Prevented Melanoma Return

1 · Reply

incipit Aug. 19 at 9:42 AM

$VSTM I am glad that the stock price is climbing again, but frustrated that every other RAS company has had a huge run but us. TGNX, ERAS, RVMD... All multibillion usd valutations

0 · Reply

Always_neutral Aug. 19 at 3:53 AM

$VSTM What really stuck me today is how there is no early morning fhort burst, not even during the lunch hour, not at the close! I have been patiently observing post-earning chart,clue is there, I am waiting to confirm the breakout.

0 · Reply

NYBomba Aug. 18 at 11:35 PM

$VSTM - current short interest is nothing… OBV is on the roof and the chart looks ready for the next step up in price … https://www.iborrowdesk.com/report/VSTM

0 · Reply